NCT07141563 2026-01-07
A Study Describing Real-World Effectiveness of Nivolumab + Chemotherapy in Neoadjuvant NSCLC
Bristol-Myers Squibb
Completed
Bristol-Myers Squibb
ARCAGY/ GINECO GROUP
Yuhan Corporation
Henan Cancer Hospital
The Christie NHS Foundation Trust
Incyte Corporation
Hoffmann-La Roche
GlaxoSmithKline